Bardin Hill Management Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-90,508
Closed -$6.81M 102
2022
Q2
$6.81M Buy
+90,508
New +$6.81M 1.78% 16